Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4481-62-3

Post Buying Request

4481-62-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4481-62-3 Usage

Uses

(+)-Betulonic Acid shows potent cytotoxic activities against PC3, MGC-803, Bcap-37, and MCF-7 cell lines.

Check Digit Verification of cas no

The CAS Registry Mumber 4481-62-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,4,8 and 1 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4481-62:
(6*4)+(5*4)+(4*8)+(3*1)+(2*6)+(1*2)=93
93 % 10 = 3
So 4481-62-3 is a valid CAS Registry Number.
InChI:InChI=1/C30H46O3/c1-18(2)19-10-15-30(25(32)33)17-16-28(6)20(24(19)30)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h19-22,24H,1,8-17H2,2-7H3,(H,32,33)/t19-,20+,21-,22+,24+,27-,28+,29+,30-/m0/s1

4481-62-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Betulonicacid

1.2 Other means of identification

Product number -
Other names Betulonic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4481-62-3 SDS

4481-62-3Synthetic route

betulonic aldehyde
4439-98-9

betulonic aldehyde

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With sodium chlorite; sodium dihydrogen phosphate monohydrate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 2h; Inert atmosphere;100%
With sodium chlorite; sodium dihydrogen phosphate monohydrate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 2h;100%
With sodium chlorite; sodium dihydrogen phosphate monohydrate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 2h; Inert atmosphere;100%
cyclohexylammonium betulonate

cyclohexylammonium betulonate

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With phosphoric acid In dichloromethane; water96%
Betulinic acid
472-15-1

Betulinic acid

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With pyridinium chlorochromate In chloroform for 2h; Ambient temperature;93%
With Jones reagent In dichloromethane; acetone at 20℃; for 0.25h; Cooling;93%
With Jones reagent In dichloromethane; acetone at 20℃; Cooling;93%
betulin
473-98-3

betulin

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Stage #1: betulin In acetone at 40℃; for 0.5h;
Stage #2: With Jones reagent at -10℃; for 4h; Solvent;
87.6%
With Jones reagent81.8%
With Jones reagent at 25℃; for 4h; Jones Oxidation;81%
betulin
473-98-3

betulin

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With Jones reagent In acetone at 0℃; for 2.25h;A 6%
B 86%
With Jones reagent In acetone at 0 - 20℃; for 3h; Inert atmosphere;A 6%
B 86%
With Jones reagent In acetone at 0 - 20℃; Inert atmosphere;A n/a
B 57%
betulin
473-98-3

betulin

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulinic aldehyde
13159-28-9, 92594-07-5

betulinic aldehyde

C

Betulinic acid
472-15-1

Betulinic acid

D

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With dipyridinium dichromate In water; N,N-dimethyl-formamideA 20%
B 7%
C 8%
D 13%
betulin
473-98-3

betulin

acetic acid
64-19-7

acetic acid

CrO3

CrO3

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulonic acid
4481-62-3

betulonic acid

C

acid C30H46O3

acid C30H46O3

Conditions
ConditionsYield
at 2℃;
pyridine
110-86-1

pyridine

betulonic aldehyde
4439-98-9

betulonic aldehyde

KMnO4

KMnO4

betulonic acid
4481-62-3

betulonic acid

betulone
7020-34-0

betulone

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With sodium chlorite; sodium dihydrogenphosphate; dihydrogen peroxide In water; acetonitrile at 20℃;347 mg
With Jones reagent
betulin diacetate
1721-69-3

betulin diacetate

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaOH / methanol; tetrahydrofuran / 168000 h / 20 °C
2: 4.8 g / Jones reagent / acetone / 7 h / 0 °C
View Scheme
betulonic aldehyde
4439-98-9

betulonic aldehyde

betulinic aldehyde
13159-28-9, 92594-07-5

betulinic aldehyde

A

Betulinic acid
472-15-1

Betulinic acid

B

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic aldehyde; betulinic aldehyde With sodium chlorite; sodium dihydrogenphosphate; 2-methyl-but-2-ene In water; tert-butyl alcohol at 20℃; for 18.5h; Inert atmosphere;
Stage #2: With sodium hydroxide In water; tert-butyl alcohol at 20℃; for 1.5h;
Stage #3: With hydrogenchloride In water for 2.5h; Overall yield = 17.8 g;
(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol
1072913-62-2

(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine; oxalyl dichloride; dimethyl sulfoxide / dichloromethane / 0.42 h / -15 °C / Inert atmosphere
2: 2-methyl-but-2-ene; sodium chlorite; sodium dihydrogen phosphate monohydrate / water; tert-butyl alcohol / 2 h / 20 °C / Inert atmosphere
View Scheme
betulonic aldehyde
4439-98-9

betulonic aldehyde

A

28-norlup-20(29)-en-3-one-17β-hydroperoxide

28-norlup-20(29)-en-3-one-17β-hydroperoxide

B

28-norlup-20(29)-en-3-one-17α-hydroperoxide

28-norlup-20(29)-en-3-one-17α-hydroperoxide

C

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With air In acetone at 20℃; for 336h;A 57.7 mg
B 32.9 mg
C 176.4 mg
betulin
473-98-3

betulin

A

betulonic aldehyde
4439-98-9

betulonic aldehyde

B

betulinic aldehyde
13159-28-9, 92594-07-5

betulinic aldehyde

C

betulonic acid
4481-62-3

betulonic acid

Conditions
ConditionsYield
With Ru/C; air In 1,3,5-trimethyl-benzene at 140℃; for 6h; Overall yield = 48 %;
betulonic acid
4481-62-3

betulonic acid

betulonic acid chloride
150841-01-3

betulonic acid chloride

Conditions
ConditionsYield
With oxalyl dichloride In dichloromethane at 20℃; for 6h; Inert atmosphere;99%
With oxalyl dichloride In benzene95%
With oxalyl dichloride In dichloromethane at 20℃; for 6h;89%
betulonic acid
4481-62-3

betulonic acid

methyl betulonate
4356-31-4

methyl betulonate

Conditions
ConditionsYield
In diethyl ether98%
With diethyl ether
Esterification;
betulonic acid
4481-62-3

betulonic acid

3-oxolupan-28-ic acid
25576-27-6

3-oxolupan-28-ic acid

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; methanol at 20℃; for 22h;98%
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; methanol at 23℃; under 760.051 Torr; for 12h;94%
With palladium on activated charcoal; hydrogen In tetrahydrofuran; methanol at 20℃;94%
betulonic acid
4481-62-3

betulonic acid

methyl iodide
74-88-4

methyl iodide

methyl betulonate
4356-31-4

methyl betulonate

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃;98%
With potassium carbonate In acetone at 25℃; for 24h;94%
With potassium carbonate In N,N-dimethyl-formamide at 23 - 40℃; for 5h; Inert atmosphere;90%
betulonic acid
4481-62-3

betulonic acid

2-hydroxy-3-oxo-lupa-1,20(29)-dien-28-oic acid
173106-22-4

2-hydroxy-3-oxo-lupa-1,20(29)-dien-28-oic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran; tert-butyl alcohol at 50℃; for 3h;97%
With potassium tert-butylate; oxygen In tert-butyl alcohol at 400℃; for 0.666667h;82%
With air; potassium tert-butylate In tert-butyl alcohol at 40℃; for 0.666667h;75%
betulonic acid
4481-62-3

betulonic acid

Betulinic acid
472-15-1

Betulinic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With aluminum isopropoxide; benzyl alcohol In tetrahydrofuran at 65℃; for 2h;
Stage #2: With sodium hydroxide In water; xylene at 130℃; for 1h;
Stage #3: With acetic acid In water Conversion of starting material;
96.3%
Stage #1: betulonic acid With aluminum isopropoxide; benzyl alcohol In tetrahydrofuran at 65℃; for 2h; Heating / reflux;
Stage #2: With sodium hydroxide; water In xylenes at 130℃; for 1h;
Stage #3: With acetic acid In water
96.3%
With sodium tetrahydroborate; isopropyl alcohol; sodium hydroxide In water for 3h;94%
betulonic acid
4481-62-3

betulonic acid

propargyl bromide
106-96-7

propargyl bromide

C28-propargylbetulonate

C28-propargylbetulonate

Conditions
ConditionsYield
With potassium carbonate In acetone at 50℃;96%
With potassium carbonate; potassium iodide at 20℃;82%
With potassium carbonate In acetone for 6h; Reflux;74%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;
betulonic acid
4481-62-3

betulonic acid

3-Oxo-18α-oleanan-28<*>19β-olide
24099-81-8

3-Oxo-18α-oleanan-28<*>19β-olide

Conditions
ConditionsYield
With sodium carbonate; trifluoroacetic acid In chloroform for 0.133333h;95%
With toluene-4-sulfonic acid In chloroform; water for 3h; Reflux;19%
With formic acid at 100℃;
With formic acid
betulonic acid
4481-62-3

betulonic acid

mercaptoacetic acid
68-11-1

mercaptoacetic acid

3,3-bis[(carboxymethyl)thio]lup-20(29)-en-28-oic acid

3,3-bis[(carboxymethyl)thio]lup-20(29)-en-28-oic acid

Conditions
ConditionsYield
In chloroform at 20℃; for 48h; Dean-Stark;95%
betulonic acid
4481-62-3

betulonic acid

(1R,3aS,5aR,5bR,11aR,E)-9-(hydroxyimino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid

(1R,3aS,5aR,5bR,11aR,E)-9-(hydroxyimino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid

Conditions
ConditionsYield
With pyridine; hydroxylamine hydrochloride at 120℃; for 4h; Microwave irradiation;94%
With pyridine; hydroxylamine hydrochloride In ethanol for 72h; Inert atmosphere;87%
With hydroxylamine; sodium acetate In ethanol
betulonic acid
4481-62-3

betulonic acid

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

2-(3-nitrobenzylidene)betulonic acid

2-(3-nitrobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-nitro-benzaldehyde In tetrahydrofuran at 0 - 20℃; for 1.5h;
93%
betulonic acid
4481-62-3

betulonic acid

4-nitrobenzaldehdye
555-16-8

4-nitrobenzaldehdye

2-(4-nitrobenzylidene)betulonic acid

2-(4-nitrobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 4-nitrobenzaldehdye In tetrahydrofuran at 0 - 20℃; for 1.5h;
93%
betulonic acid
4481-62-3

betulonic acid

(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-isocyanato-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)octadecahydro-1H-cyclopenta[a]chrysen-9(5bH)-one
628308-21-4

(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a-isocyanato-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)octadecahydro-1H-cyclopenta[a]chrysen-9(5bH)-one

Conditions
ConditionsYield
With diphenyl phosphoryl azide; N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 20 - 102℃; for 16.66h; Concentration; Reagent/catalyst; Temperature; Time; Inert atmosphere;92%
With diphenyl phosphoryl azide; triethylamine In 1,4-dioxane for 18.5h; Reflux;63.2%
With diphenyl phosphoryl azide; triethylamine In 1,4-dioxane for 18.5h; Reflux; Inert atmosphere;63.2%
Multi-step reaction with 2 steps
1: oxalyl chloride / benzene / 2 h / 20 - 22 °C
2: 0.38 g / NaN3 / acetone / 6 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 95 percent / oxalyl chloride / benzene
2: NaN3 / acetone / 6 h / 20 - 22 °C
View Scheme
betulonic acid
4481-62-3

betulonic acid

2,6-dichlorobenzaldehyde
83-38-5

2,6-dichlorobenzaldehyde

2-(2,6-dichlorobenzylidene)betulonic acid

2-(2,6-dichlorobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 2,6-dichlorobenzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
92%
5-bromo-2-furancarboxaldehyde
1899-24-7

5-bromo-2-furancarboxaldehyde

betulonic acid
4481-62-3

betulonic acid

2-{(5-bromofuran-2-yl)methylene}betulonic acid

2-{(5-bromofuran-2-yl)methylene}betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 5-bromo-2-furancarboxaldehyde In tetrahydrofuran at 0 - 20℃; for 1.7h;
92%
betulonic acid
4481-62-3

betulonic acid

5-bromo-2-methoxybenzaldehyde
25016-01-7

5-bromo-2-methoxybenzaldehyde

2-(5-bromo-2-methoxybenzylidene)betulonic acid

2-(5-bromo-2-methoxybenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 5-bromo-2-methoxybenzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
92%
4-nitrophenyl azide
1516-60-5

4-nitrophenyl azide

betulonic acid
4481-62-3

betulonic acid

benzylamine
100-46-9

benzylamine

1′-benzyl-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

1′-benzyl-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

Conditions
ConditionsYield
In toluene at 100℃; for 24h; Molecular sieve;92%
3,5-dimethoxybenzylamine
34967-24-3

3,5-dimethoxybenzylamine

4-nitrophenyl azide
1516-60-5

4-nitrophenyl azide

betulonic acid
4481-62-3

betulonic acid

1′-(3,5-dimethoxybenzyl)-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

1′-(3,5-dimethoxybenzyl)-1H′-lup-2-eno-[2,3-d][1,2,3]-triazole-28-oic acid

Conditions
ConditionsYield
In toluene at 100℃; for 24h; Molecular sieve;92%
betulonic acid
4481-62-3

betulonic acid

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

2-(4-bromobenzylidene)betulonic acid

2-(4-bromobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 4-bromo-benzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
91%
m-bromobenzoic aldehyde
3132-99-8

m-bromobenzoic aldehyde

betulonic acid
4481-62-3

betulonic acid

2-(3-bromobenzylidene)betulonic acid

2-(3-bromobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: m-bromobenzoic aldehyde In tetrahydrofuran at 0 - 20℃; for 1.5h;
91%
betulonic acid
4481-62-3

betulonic acid

ortho-bromobenzaldehyde
6630-33-7

ortho-bromobenzaldehyde

2-(2-bromobenzylidene)betulonic acid

2-(2-bromobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: ortho-bromobenzaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
91%
betulonic acid
4481-62-3

betulonic acid

1-naphthaldehyde
66-77-3

1-naphthaldehyde

2-(naphthalene-1-ylmethylene)betulonic acid

2-(naphthalene-1-ylmethylene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 1-naphthaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
91%
betulonic acid
4481-62-3

betulonic acid

3-(hydroxyimino)lup-20(29)-en-28-oic acid
38301-42-7

3-(hydroxyimino)lup-20(29)-en-28-oic acid

Conditions
ConditionsYield
With hydroxylamine hydrochloride In pyridine for 2h; Heating;90%
With pyridine; hydroxylamine hydrochloride In methanol for 16h; Reflux;84%
With pyridine; hydroxylamine hydrochloride at 20℃;72.4%
betulonic acid
4481-62-3

betulonic acid

benzyl chloride
100-44-7

benzyl chloride

benzyl (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-oxo-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate
203576-71-0

benzyl (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-oxo-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate

Conditions
ConditionsYield
With potassium carbonate for 2h; Reflux;90%
3-thiophene carboxaldehyde
498-62-4

3-thiophene carboxaldehyde

betulonic acid
4481-62-3

betulonic acid

2-(thiophen-3-ylmethylene)betulonic acid

2-(thiophen-3-ylmethylene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-thiophene carboxaldehyde In tetrahydrofuran at 0 - 20℃; for 1h;
90%
3-pyridinecarboxaldehyde
500-22-1

3-pyridinecarboxaldehyde

betulonic acid
4481-62-3

betulonic acid

2-(pyridin-3-ylmethylene)betulonic acid

2-(pyridin-3-ylmethylene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-pyridinecarboxaldehyde In tetrahydrofuran at 0 - 20℃; for 2h;
90%
betulonic acid
4481-62-3

betulonic acid

3-bromo-4-fluorobenzaldehyde
77771-02-9

3-bromo-4-fluorobenzaldehyde

2-(3-bromo-4-fluorobenzylidene)betulonic acid

2-(3-bromo-4-fluorobenzylidene)betulonic acid

Conditions
ConditionsYield
Stage #1: betulonic acid With sodium hydride In tetrahydrofuran at 0℃; for 0.166667h;
Stage #2: 3-bromo-4-fluorobenzaldehyde In tetrahydrofuran at 0 - 20℃; for 1.5h;
90%

4481-62-3Relevant articles and documents

A convergent synthesis of novel alkyne–azide cycloaddition congeners of betulinic acid as potent cytotoxic agent

Dangroo, Nisar A.,Singh, Jasvinder,Rath, Santosh K.,Gupta, Nidhi,Qayum, Arem,Singh, Shashank,Sangwan, Payare L.

, p. 1 - 12 (2017)

In an endeavour to develop potent anti-tumor agents from betulinic acid (BA), a series of C-28 derived 1,2,3-triazolyl derivatives were designed and synthesized by employing Cu(I) catalyzed Huisgen 1,3-dipolar cycloaddition reaction. All the derivatives were evaluated for cytotoxic activity by MTT assay against five different human cancer cell lines: lung (A549), colon (HCT116), prostate (PC3), pancreatic (MIA PaCa-2) and breast (T47D). The data revealed that compounds 11c, 11d, 11g, 11h and 13a possess most promising cytotoxic potential. The compound 11h was one of the most active compounds, with IC50 values in the range of 4–6?μM against all the five cancer cell lines. The results of this study suggested that derivatives with free –OH (11c, 11d and 11g) and free –COOH (11h and 13a) substitutions in the triazole moiety introduced at the C-28 position significantly improved the anti-tumor activity and may be the favourable position to synthesize potent anticancer leads from BA. Introduction of a non polar alkyl groups at C-28 position (10, 12 and 14) resulted in the significant loss of the activity. Further, DAPI staining, ROS generation and wound healing experiments revealed that compound 11h induces apoptosis in HCT-116 cells.

Synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage

Khlebnicova, Tatyana S.,Shishkina, Svetlana V.,Zicāne, Daina,Piven, Yuri A.,Tetere, Zenta,Baranovsky, Alexander V.,Rāvi?a, Irisa,Lakhvich, Fedor A.,Kumpi??, Viktors,Rijkure, Inese,Mieri?a, Inese,Peipi??, Uldis,Turks, Māris

, p. 77 - 89 (2017)

An efficient protocol for the synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage has been developed from naturally accessible precursor betulin. For the first time a series of betulonic acid-indazolone hybrids have been synthesized via an acylation of corresponding 6,7-dihydro-1H-indazol-4(5H)-one oximes with betulonic acid chloride. Diastereoselective reduction of the obtained betulonic acid conjugates with NaBH4resulted in a formation of betulinic acid-indazolone hybrids in excellent yields. The configuration of the key compounds has been fully established by X-ray and 2D NMR analysis.

Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity

Wang, Qiang,Li, Yujiang,Zheng, Liyun,Huang, Xiaowan,Wang, Yanli,Chen, Chin-Ho,Cheng, Yung-Yi,Morris-Natschke, Susan L.,Lee, Kuo-Hsiung

, p. 2290 - 2293 (2020)

Novel betulinic/betulonic acid-nucleoside hybrids were synthesized as possible new anti-HIV agents. Among the synthesized hybrids, two compounds were highly effective against HIV. Compared with AZT and DSB, compounds 10a (IC50= 0.0078 μM, CC50= 9.6 μM) and 10b (IC50= 0.020 μM, CC50= 23.8 μM) showed more potent or equipotent, respectively, anti-HIV activity but displayed lower cytotoxicity.

Synthesis and anti-HCV entry activity studies of β-cyclodextrin- pentacyclic triterpene conjugates

Xiao, Sulong,Wang, Qi,Si, Longlong,Shi, Yongying,Wang, Han,Yu, Fei,Zhang, Yongmin,Li, Yingbo,Zheng, Yongxiang,Zhang, Chuanling,Wang, Chunguang,Zhang, Lihe,Zhou, Demin

, p. 1060 - 1070 (2014)

In our previous studies, oleanolic acid (OA) and echinocystic acid (EA), isolated from Dipsacus asperoides, were found to have anti-HCV entry properties. The major issue for members of this type of triterpene is their low water solubility. In this study, a series of new water-soluble triazole-bridged β-cyclodextrin (CD)-pentacyclic triterpene conjugates were synthesized via click chemistry. Thanks to the attached β-CD moiety, all synthesized conjugates showed lower hydrophobicity (Alog P) than their parent compounds. Several conjugates exhibited moderate anti-HCV entry activity. With the exception of per-O-methylated β-CD-pentacyclic triterpene conjugates, all other conjugates showed no cytotoxicity based on an alamarBlue assay carried out with HeLa, HepG2, MDCK, and 293T cells. More interestingly, the hemolytic activity of these conjugates disappeared upon the introduction of β-CDs. Easy access to such conjugates that combine the properties of β-CD and pentacyclic triterpenes may provide a way to obtain a new class of anti-HCV entry inhibitors. An awesome CD collection: A series of water-soluble triazole-bridged β-cyclodextrin (CD)-pentacyclic triterpene conjugates were synthesized, and their hydrophobicity, anti-HCV entry activities, and toxicity were studied. Easy access to such conjugates may provide a way to obtain a new class of anti-HCV entry inhibitors.

Lupane triterpenes and derivatives with antiviral activity

Baltina,Flekhter,Nigmatullina,Boreko,Pavlova,Nikolaeva,Savinova,Tolstikov

, p. 3549 - 3552 (2003)

Betulin and betulinic acid have been modified at the C-3 and C-28 positions and the antiviral activity of derivatives has been evaluated in vitro. It was found that simple modifications of the parent structure of lupane triterpenes produced highly effective agents against influenza A and herpes simplex type 1 viruses.

Betulonic acid—cyclodextrins inclusion complexes

Sbarcea, Laura,Lede?i, Adriana,Udrescu, Lucre?ia,V?ru?, Renata-Maria,Barvinschi, Paul,Vlase, Gabriela,Lede?i, Ionu?

, p. 2787 - 2797 (2019)

Betulonic acid (BA) is a pentacyclic lupane-type triterpenoid possessing valuable pharmacological activities, exhibiting very low water solubility. Inclusion complexes between the substance and cyclodextrins (CDs) were obtained in order to improve its solubility and consequently its bioavailability. The aim of this study was to investigate the guest–host interaction of BA with γ-cyclodextrin (γ-CD) and its derivative, 2-hydroxypropyl-γ-cyclodextrin (HP-γ-CD), in solution and in solid state in order to prove the formation of inclusion complexes between the components. The kneading method was used for the inclusion complexes preparation, and different analytical techniques such as thermal analysis, powder X-ray diffractometry, universal attenuated total reflectance Fourier transform IR spectroscopy (UATR-FTIR) and UV spectroscopy were employed to investigate the interaction between substances. The stoichiometry of the inclusion complex BA/HP-γ-CD was found to be 1:1 by employing continuous variation method, and the apparent stability constant was calculated as 1855.55?M?1 using Benesi–Hildebrand equation. Structural studies of the inclusion complexes were carried out using molecular modeling techniques in order to explain the complexation mechanism. The results of this study confirm the formation of inclusion complexes between BA and cyclodextrins both in solution and in solid state.

Modified Method for Measuring the Solubility of Pharmaceutical Compounds in Organic Solvents by Visual Camera

Tang, Ning,Shi, Wei,Yan, Weidong

, p. 35 - 40 (2016)

A modified synthetic method with a high definition visual camera technique for measuring the solubility of solutes in solvents or mixed solvents was proposed. To verify the reliability of the experimental apparatus, the solubility of NH4Cl in water was determined at different temperatures. The relative standard errors were less than 1%, compared to the literature data. The solubilities of betulonic acid in six organic solvents from (278.15 to 313.15) K were measured and correlated with the Apelblat equation and universal quasichemical equation, respectively. The modified method was quite concise and user-friendly, and made the process of dissolution to become visualized and automatic.

3-Epihydroxy lup-20(29)-en-19(28)-olide: partial synthesis, antitopoisomerase activity, and 3D molecular docking

Mandal, Amitava,Ghosh, Ashim,Ghosh, Shilpi,Shil, Suranjan,Bothra, Asim Kumar,Ghosh, Pranab

, p. 1087 - 1095 (2016)

A novel method for the partial synthesis of the rare triterpenoid, 3-epihydroxy lup-20(29)-en-19(28)-olide, and 1 from betulinic acid is reported. The binding efficiency, mode of binding for different compounds to the central catalytic domain of topoisomerase IIα, was calculated from a complete 3D molecular docking study on the crystal structure of the enzyme (1bgw, pdb). The compounds 1, 2b, and 2d showed a dose-dependent inhibition of catalytic activity of topoisomerase IIα.

Method for Preparing Betulonic Acid from Betula pendula Birch Bark

Levdanskii,Levdanskii,Kuznetsov

, p. 766 - 768 (2016)

-

Microbial transformations of two lupane-type triterpenes and anti-tumor-promoting effects of the transformation products

Akihisa, Toshihiro,Nishino, Hoyoku,Takamine, Yoshio,Yoshizumi, Kazuo,Tokuda, Harukuni,Kimura, Yumiko,Ukiya, Motohiko,Nakahara, Toro,Yokochi, Toshihiro,Ichiishi, Eiichiro

, p. 278 - 282 (2002)

Microbial transformation of betulin (1), a lupane-type triterpene obtained from the bark extract of white birch (Betula platyphylla Sukatshev var. japonica), and its chemical oxidation product, betulonic acid (2), by the fungus Chaetomium longirostre yielded 4,28-dihydroxy-3,4-seco-lup-20(29)-en-3-oic acid (3) and 4-hydroxy-3,4-seco-lup-20(29)-ene-3,28-dioic acid (4) from 1, and 4,7β,17-trihydroxy-3,4-seco-28-norlup-20(29)-en-3-oic acid (5) and 7β,15α-dihydoxy-3-oxolup-20(29)-en-28-oic acid (6) from 2. The four metabolites, 3-6, along with 1 and 2, were evaluated for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells as a primary screening test for inhibitors of tumor promotion. All of the triterpenes tested showed potent inhibitory effects, with the four metabolites 3-6 exhibiting the more potent effects.

Betulinic acid derivative and application thereof

-

Paragraph 0042-0044; 0049, (2021/06/22)

The invention belongs to the field of medicines, and particularly relates to betulinic acid derivatives and application thereof. The invention mainly provides a compound as shown in the following formula I, a stereoisomer, nitrogen oxide, pharmaceutically acceptable salt or prodrug of the compound and application of the compound to preparation of drugs, and the drugs are used for preventing or treating liver diseases or protecting the liver.

The Effect of Experimental BCG Antigen–Betulin-Derived Conjugates on the Guinea Pig Immunological Response

Koshkin, I. N.,Kulakov, I. V.,Vlasenko, V. S.

, p. 837 - 844 (2021/08/25)

Abstract: The immunopotentiating properties of BCG vaccine strain antigen conjugated with betulin derivatives have been evaluated. The experiments were carried out on agouti guinea pigs (n = 20). The animals of the experimental groups (n = 5) were immunized with the following antituberculosis drugs: group 1, with antigens of the BCG vaccine strain conjugated with betulinic acid; group 2, with BCG antigens conjugated with betulonic acid; and group 3, with the BCG vaccine. The animals of the control group (n = 5) were injected with a saline solution. All the animals were infected with a virulent culture of Mycobacterium bovis (strain 8) on day 30 after the administration of antituberculosis drugs. The blood sampling for the assessment of the immune status was conducted on day 30 after the administration of drugs and day 30 after the infection with M. bovis. The designed conjugates were found to display immunopotentiating activity characterized by a 1.7–3.8-fold increase in the number of immunocompetent cells and an increase in the neutrophil functional activity observed to a greater degree in the guinea pig group 2. After infection with M. bovis some key parameters of the immune system, such as a T-lymphocyte count and the activity of enzymatic (myeloperoxidase) and nonenzymatic (cationic proteins) bactericidal systems of neutrophilic granulocytes significantly increased in groups 2 and 3, which implied the highest antituberculosis activity of the agents administered to these animals. The guinea pigs were euthanized 45 days after the infection with M. bovis. The next pathoanatomical experiments proved that the vaccine strain conjugates with betulonic acid and the BCG vaccine induced marked resistance against the pathogenic mycobacteria. The protection indexes for these agents were approximately the same and achieved 66 and 71%, respectively.

Enhancement of the antioxidant and skin permeation properties of betulin and its derivatives

Duchnik, Wiktoria,Günther, Andrzej,Klimowicz, Adam,Kucharski, ?ukasz,Makuch, Edyta,Nowak, Anna,Pe?ech, Robert

, (2021/06/21)

This study investigated the antioxidant activity DPPH, ABTS, and Folin–Ciocalteu methods of betulin (compound 1) and its derivatives (compounds 2–11). Skin permeability and accumulation associated with compounds 1 and 8 were also examined. Identification of the obtained products (compound 2–11) and betulin isolated from plant material was based on the analysis of1H-NMR and13C-NMR spectra. The partition coefficient was calculated to determine the lipophilicity of all compounds. In the next stage, the penetration through pig skin and its accumulation in the skin were evaluated of ethanol vehicles containing compound 8 (at a concentration of 0.226 mmol/dm3), which was characterized by the highest antioxidant activity. For comparison, penetration studies of betulin itself were also carried out. Poor solubility and the bioavailability of pure compounds are major constraints in combination therapy. However, we observed that the ethanol vehicle was an enhancer of skin permeation for both the initial betulin and compound 8. The betulin 8 derivative showed increased permeability through biological membranes compared to the parent betulin. The paper presents the transformation of polycyclic compounds to produce novel derivatives with marked antioxidant activities and as valuable intermediates for the pharmaceutical industry. Moreover, the compounds contained in the vehicles, due to their mechanism of action, can have a beneficial effect on the balance between oxidants and antioxidants in the body, minimizing the effects of oxidative stress. The results of this work may contribute to knowledge regarding vehicles with antioxidant potential. The use of vehicles for this type of research is therefore justified.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4481-62-3